Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1996 Sep;40(9):2137–2141. doi: 10.1128/aac.40.9.2137

Bactericidal activity of single dose of clarithromycin plus minocycline, with or without ofloxacin, against Mycobacterium leprae in patients.

B Ji 1, P Jamet 1, E G Perani 1, S Sow 1, C Lienhardt 1, C Petinon 1, J H Grosset 1
PMCID: PMC163487  PMID: 8878595

Abstract

Fifty patients with newly diagnosed lepromatous leprosy were allocated randomly to one of five groups and treated with either a month-long standard regimen of multidrug therapy (MDT) for multibacillary leprosy, a single dose of 600 mg of rifampin, a month-long regimen with the dapsone (DDS) and clofazimine (CLO) components of the standard MDT, or a single dose of 2,000 mg of clarithromycin (CLARI) plus 200 mg of minocycline (MINO), with or without the addition of 800 mg of ofloxacin (OFLO). At the end of 1 month, clinical improvement accompanied by significant decreases of morphological indexes in skin smears was observed in about half of the patients of each group. A significant bactericidal effect was demonstrated in the great majority of patients in all five groups by inoculating the footpads of mice with organisms recovered from biopsy samples obtained before and after treatment. Rifampin proved to be a bactericidal drug against Mycobacterium leprae more potent than any combination of the other drugs. A single dose of CLARI-MINO, with or without OFLO, displayed a degree of bactericidal activity similar to that of a regimen daily of doses of DDS-CLO for 1 month, suggesting that it may be possible to replace the DDS and CLO components of the MDT with a monthly dose of CLARI-MINO, with or without OFLO. However, gastrointestinal adverse events were quite frequent among patients treated with CLARI-MINO, with or without OFLO, and may be attributed to the higher dosage of CLARI or MINO or to the combination of CLARI-MINO plus OFLO. In future trials, therefore, we propose to reduce the dosages of the drugs to 1,000 mg of CLARI, 100 mg of MINO, and 400 mg of OFLO.

Full Text

The Full Text of this article is available as a PDF (181.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen J. C. Minocycline. Ann Intern Med. 1976 Oct;85(4):482–487. doi: 10.7326/0003-4819-85-4-482. [DOI] [PubMed] [Google Scholar]
  2. Chan G. P., Garcia-Ignacio B. Y., Chavez V. E., Livelo J. B., Jimenez C. L., Parrilla M. L., Franzblau S. G. Clinical trial of clarithromycin for lepromatous leprosy. Antimicrob Agents Chemother. 1994 Mar;38(3):515–517. doi: 10.1128/aac.38.3.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fajardo T. T., Jr, Villahermosa L. G., dela Cruz E. C., Abalos R. M., Franzblau S. G., Walsh G. P. Minocycline in lepromatous leprosy. Int J Lepr Other Mycobact Dis. 1995 Mar;63(1):8–17. [PubMed] [Google Scholar]
  4. Gelber R. H., Fukuda K., Byrd S., Murray L. P., Siu P., Tsang M., Rea T. H. A clinical trial of minocycline in lepromatous leprosy. BMJ. 1992 Jan 11;304(6819):91–92. doi: 10.1136/bmj.304.6819.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gelber R. H., Murray L. P., Siu P., Tsang M., Rea T. H. Efficacy of minocycline in single dose and at 100 mg twice daily for lepromatous leprosy. Int J Lepr Other Mycobact Dis. 1994 Dec;62(4):568–573. [PubMed] [Google Scholar]
  6. Gelber R. H. Successful treatment of a lepromatous patient with clarithromycin. Int J Lepr Other Mycobact Dis. 1995 Mar;63(1):113–115. [PubMed] [Google Scholar]
  7. Grosset J. H., Ji B. H., Guelpa-Lauras C. C., Perani E. G., N'Deli L. N. Clinical trial of pefloxacin and ofloxacin in the treatment of lepromatous leprosy. Int J Lepr Other Mycobact Dis. 1990 Jun;58(2):281–295. [PubMed] [Google Scholar]
  8. Ji B., Grosset J. H. Recent advances in the chemotherapy of leprosy. Lepr Rev. 1990 Dec;61(4):313–329. doi: 10.5935/0305-7518.19900029. [DOI] [PubMed] [Google Scholar]
  9. Ji B., Jamet P., Perani E. G., Bobin P., Grosset J. H. Powerful bactericidal activities of clarithromycin and minocycline against Mycobacterium leprae in lepromatous leprosy. J Infect Dis. 1993 Jul;168(1):188–190. doi: 10.1093/infdis/168.1.188. [DOI] [PubMed] [Google Scholar]
  10. Ji B., Perani E. G., Grosset J. H. Effectiveness of clarithromycin and minocycline alone and in combination against experimental Mycobacterium leprae infection in mice. Antimicrob Agents Chemother. 1991 Mar;35(3):579–581. doi: 10.1128/aac.35.3.579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ji B., Perani E. G., Petinom C., Grosset J. H. Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice. Antimicrob Agents Chemother. 1996 Feb;40(2):393–399. doi: 10.1128/aac.40.2.393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ji B., Perani E. G., Petinom C., N'Deli L., Grosset J. H. Clinical trial of ofloxacin alone and in combination with dapsone plus clofazimine for treatment of lepromatous leprosy. Antimicrob Agents Chemother. 1994 Apr;38(4):662–667. doi: 10.1128/aac.38.4.662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ji B., Perani E. G., Petinon C., Grosset J. H. Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice. Int J Lepr Other Mycobact Dis. 1992 Dec;60(4):556–561. [PubMed] [Google Scholar]
  14. Ridley D. S., Jopling W. H. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255–273. [PubMed] [Google Scholar]
  15. Shepard C. C., McRae D. H. A method for counting acid-fast bacteria. Int J Lepr Other Mycobact Dis. 1968 Jan-Mar;36(1):78–82. [PubMed] [Google Scholar]
  16. Shepard C. C. Statistical analysis of results obtained by two methods for testing drug activity against Mycobacterium leprae. Int J Lepr Other Mycobact Dis. 1982 Mar;50(1):96–101. [PubMed] [Google Scholar]
  17. Xiong J. H., Ji B., Perani E. G., Pétinon C., Grosset J. H. Further study of the effectiveness of single doses of clarithromycin and minocycline against Mycobacterium leprae in mice. Int J Lepr Other Mycobact Dis. 1994 Mar;62(1):37–42. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES